Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P020056/S064

Natrelle Silicone-Filled Breast Implants and Natrelle INSPIRA Silicone-Filled Breast Implants

Allergan · Decision date Sep 29, 2026

MEDTECHLEDGER EXPLANATIONP020056/S064

What did the FDA approve?

The FDA database entry records an approval decision dated September 29, 2026, for supplement S064 to PMA P020056, covering Natrelle Silicone-Filled Breast Implants and Natrelle INSPIRA Silicone-Filled Breast Implants from Allergan. The decision type is APPR, and the statement field describes the action as approval for revised labeling to include the results of the BIFS Arm study.

The supplement is classified as a Normal 180 Day Track with no user fee, and the stated reason is Labeling Change - PAS. The device category is a noninflatable, internal, silicone gel-filled breast prosthesis under product code FTR. The database fields do not state what specific labeling text changed, what the BIFS Arm study measured, or whether the results support any safety or effectiveness conclusion.

FDA approval order statement

approval for revised labeling to include the results of the BIFS Arm study.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
General, Plastic Surgery
Decision date
Sep 29, 2026
FDA change category
Labeling Change - PAS

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P020056/S064
Regulatory pathway
PMA supplement
Applicant
Allergan
Product code
FTR
Decision code
APPR
Decision date
Sep 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, breast, noninflatable, internal, silicone gel-filled.

Applicant
Allergan
Product code
FTR
FDA device class
3

For the original device and its historical approval scope, see PMA P020056. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P020056 · Original PMA

    NATRELLE SILICONE-FILLED BREAST IMPLANTS

  2. P020056/S064 received

    Application receipt date recorded by FDA.

  3. P020056/S064 · FDA decision

    Normal 180 Day Track No User Fee

Timeline entries are records held by MedtechLedger for P020056. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P020056

Product / regulatory recordCompanyPathwayDecision dateSource
AllerganPMA approvalNov 17, 2006FDA

Explore the linked device profile

Other records with product code FTR

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Allergan

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
2525 Dupont Dr., Irvine, CA, 92612

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records